The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.
about
Megacities as sources for pathogenic bacteria in rivers and their fate downstreamChinese herbal medicines for treating skin and soft-tissue infectionsBiological cost of rifampin resistance from the perspective of Staphylococcus aureusPrior antimicrobial therapy in the hospital and other predisposing factors influencing the usage of antibiotics in a pediatric critical care unitUrinary tract infection in the setting of vesicoureteral refluxThe fitness costs of antibiotic resistance mutationsAdherence and drug resistance: predictions for therapy outcomeThe Multidrug Resistance IncA/C Transferable Plasmid Encodes a Novel Domain-swapped Dimeric Protein-disulfide IsomeraseMolecular properties of bacterial multidrug transportersThe release of genetically modified crops into the environment. Part II. Overview of ecological risk assessmentAntibacterial prescribing and antibacterial resistance in English general practice: cross sectional studyThe role of compensatory mutations in the emergence of drug resistanceEvolutionary epidemiology of drug-resistance in spaceDynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatmentEvaluation of a Mixing versus a Cycling Strategy of Antibiotic Use in Critically-Ill Medical Patients: Impact on Acquisition of Resistant Microorganisms and Clinical OutcomesA model-guided analysis and perspective on the evolution and epidemiology of antibiotic resistance and its futureMaintaining fluoroquinolone class efficacy: review of influencing factors.Inhibition of efflux transporter-mediated fungicide resistance in Pyrenophora tritici-repentis by a derivative of 4'-hydroxyflavone and enhancement of fungicide activity.Climate negotiations under scientific uncertainty.Using hospital antibiogram data to assess regional pneumococcal resistance to antibioticsBiological activities of retro and diastereo analogs of a 13-residue peptide with antimicrobial and hemolytic activities.Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice--the Prescription Peer Academic Detailing (Rx-PAD) Study [NCT00272155]Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).Investigation of antimicrobial use at a tertiary care hospital in Southern Punjab, Pakistan using WHO methodology.The abundance of antibiotic resistance genes in human guts has correlation to the consumption of antibiotics in animalRisk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence studyAntibiotic prescriptions in primary health care in a rural population in Crete, GreeceAntimicrobial prescribing.Antibiotic dose impact on resistance selection in the community: a mathematical model of beta-lactams and Streptococcus pneumoniae dynamicsAntimicrobial Stewardship Lessons From Mupirocin Use and Resistance in Methicillin-Resitant Staphylococcus AureusThe epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions.The pharmacist's role in promoting optimal antimicrobial use.A model of antibiotic-resistant bacterial epidemics in hospitals.Non prescribed sale of antibiotics in Riyadh, Saudi Arabia: a cross sectional studyEvidence of clonal dissemination of multidrug-resistant Streptococcus pneumoniae in Hong Kong.Molecular evolution in a multidrug-resistant lineage of Streptococcus pneumoniae: emergence of strains belonging to the serotype 6B Icelandic clone that lost antibiotic resistance traitsLimiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.Divergence in fitness and evolution of drug resistance in experimental populations of Candida albicans
P2860
Q21296756-85925A45-C388-4A7D-8CAA-E3498D9434B9Q24194810-343CE7BF-8836-4907-9B58-CF99DFBE5E3DQ24538819-CD2E4B46-8854-493C-A602-799D778AE54DQ24803615-B0FAC262-F34F-4CF1-9277-9F3F2609C002Q26740621-DFDF4109-33F2-4A40-BE43-C9F789A82D92Q26825334-8B0EC03E-075F-47C9-B2E9-9A090AA97755Q27477742-D7BE1422-1AB4-4FEF-8A30-60A08045750FQ27680786-EAD067FA-8B71-47D4-A403-1FD171D9E4CAQ28139376-84D2B23C-9C15-4616-9D8C-0181A534256BQ28203960-0743CFD9-DACA-4022-BB09-F503A071EFC5Q28363120-1EDC8381-E352-478E-BF3D-E7C982E1E637Q28469058-B642CBF8-A58C-4DE7-A500-C93DAF16B70DQ28475118-4BC933EC-B4F0-4FCD-9208-ACB10A606D1AQ28478602-AA69EB48-F233-4A9F-9311-F156B9711B83Q28550780-25A4501D-8D72-42F2-9822-95CAEFA45131Q28655580-36E24159-5895-4023-9AB9-16C15E179472Q30310427-2F15E6E1-C27D-42CC-B785-467331F968E7Q30320212-40090DCE-C36A-4D1B-B667-9738C3F32717Q30572541-949503EE-2416-4AA1-8133-BB59C38B5317Q30772203-665BABD5-6340-468A-9D16-384ED5EA77C3Q31902860-B211E2F4-AD8D-4561-BEA4-765351FD4DF9Q33246841-5F437235-9C9C-4447-B6F0-57B273D24E3CQ33264145-4450BB6A-869C-4FBF-BBD5-4E53C789C69BQ33571285-EB7D4420-E32A-4C7A-95C0-5E0D70C1893BQ33617774-931C036D-C001-457C-AD3C-DD7BF90B9F6BQ33779260-E64364F2-BFA7-4E47-BEE2-374AD0EDF138Q33817614-D062186C-BD93-4904-9D60-DB39EA3E79C8Q33820308-8B605AFC-FD95-4FD9-B8EC-AF8CFF27DB90Q33859322-C2D6BA1B-CA76-437F-8419-22D1063D5DABQ33876556-5E14FADD-942D-4904-BC2A-125B9B1C20DDQ33878840-B46B7523-7139-4DC2-A7E7-0C4B1001EE3DQ33890335-ED410BEC-D82E-4421-9F57-CD888A4273DDQ33942876-104D8720-207D-4C1E-9FB3-7816B624050DQ33947937-0EB881EE-30F6-47AA-9239-9191ADB7FDB0Q33953851-2295BC92-709B-42FA-A0F7-707B70604FD5Q33962435-058445B3-D418-4C5D-A82A-97AC7FFA50F8Q33966335-BB400ADF-B6A4-4B9C-A5C0-DE13E302E4C7Q33975560-9A7CA915-45DD-4581-9FA2-7E3E048A97FAQ33983518-3D62AA51-3952-4A5F-A643-BB631AADE42AQ33996119-78FCEC25-6009-4000-9D74-17690FA1839A
P2860
The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The relationship between the v ...... d the frequency of resistance.
@ast
The relationship between the v ...... d the frequency of resistance.
@en
The relationship between the v ...... d the frequency of resistance.
@nl
type
label
The relationship between the v ...... d the frequency of resistance.
@ast
The relationship between the v ...... d the frequency of resistance.
@en
The relationship between the v ...... d the frequency of resistance.
@nl
prefLabel
The relationship between the v ...... d the frequency of resistance.
@ast
The relationship between the v ...... d the frequency of resistance.
@en
The relationship between the v ...... d the frequency of resistance.
@nl
P2093
P2860
P356
P1476
The relationship between the v ...... d the frequency of resistance.
@en
P2093
D J Austin
K G Kristinsson
R M Anderson
P2860
P304
P356
10.1073/PNAS.96.3.1152
P407
P577
1999-02-01T00:00:00Z